FDA Inspection
Medivera Compounding PharmacyMedivera Compounding Pharmacy – FDA Inspection, Nov 13, 2014
Record Details
This FDA Inspection record concerns Medivera Compounding Pharmacy, with an inspection on November 13, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 13, 2014
- Product Type
- Drugs
View Company Profile
ID · 6b03ac3f-a10c-42bd-bde1-1537ae37e6fb
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 901769
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- 483 Response
FDA Citations
9- 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.94(b)Protection from external factors
- 21 CFR 211.167(a)Sterility/pyrogen-free testing
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.42(d)Penicillin processing area not kept separate
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medivera Compounding Pharmacy
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 19, 2017 | Not classified | Detroit District Office |
Other documents for Medivera Compounding Pharmacy
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.